Adrenoceptors in GtoPdb v.2023.3
Jillian G. Baker(Nottingham University Hospitals NHS Trust), Roger J. Summers(Australian Regenerative Medicine Institute), Robert M. Graham(University of Glasgow), Martin C. Michel(Johannes Gutenberg University Mainz), Kenneth P. Minneman(Emory University), Poornima Balaji(Victor Chang Cardiac Research Institute), Richard A. Bond(University of Houston), Sergio Parra(University of Michigan–Ann Arbor), Dianne M. Perez(Cerner (United States)), David B. Bylund, Rebecca Hills(University of Edinburgh), J. Paul Hieble(GlaxoSmithKline (Netherlands)), Douglas C. Eikenburg(University of Houston)
Cited by 0
Related Papers
Structure of a β1-adrenergic G-protein-coupled receptor
|Nature|2008|1.3k
XVI. International Union of Pharmacology Recommendations for the Nomenclature of Neuropeptide Y, Peptide YY, and Pancreatic Polypeptide Receptors
|Pharmacological Reviews|1998|893
The structural basis for agonist and partial agonist action on a β1-adrenergic receptor
|Nature|2011|623
The selectivity of β‐adrenoceptor agonists at human β<sub>1</sub>‐, β<sub>2</sub>‐ and β<sub>3</sub>‐adrenoceptors
|British Journal of Pharmacology|2010|586
The selectivity of <i>β</i>‐adrenoceptor antagonists at the human <i>β</i>1, <i>β</i>2 and <i>β</i>3 adrenoceptors
|British Journal of Pharmacology|2005|535